Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma

被引:30
|
作者
Fargion, S
Stazi, MA
Fracanzani, AL
Mattioli, M
Sampietro, M
Tavazzi, D
Bertelli, C
Patriarca, V
Mariani, C
Fiorelli, G
机构
[1] Univ Milan, IRCCS, Osped Maggiore, Dipartimento Med Interna, I-20133 Milan, Italy
[2] Ist Super Sanita, I-00161 Rome, Italy
关键词
HBV; HCV infection; alcohol abuse; C282YH63D mutations;
D O I
10.1006/bcmd.2001.0411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The possible role of iron in facilitating the development of liver cancer is still debated, The aims of this study were to define the prevalence of the mutations 845G -->A, and 187C -->G (C282Y and H63D) in the HFE gene associated with hereditary hemochromatosis in Italian patients with hepatocellular carcinoma occurring in cirrhosis and to analyze the interaction between these mutations and other established risk factors for hepatocellular carcinoma. The HFE gene mutations, performed by polymerase chain reaction, were analyzed in 81 patients (63 males, 18 females) with hepatocellular carcinoma. None of the patients had a phenotype compatible with homozygous hereditary hemochromatosis. Interaction between I HFE mutations and exogenous risk factors was analyzed by collecting information on alcohol consumption, hepatitis B and C virus infections, and iron status at the time of diagnosis of chronic liver disease. This analysis was performed only in males to rule out gender influence on patients' iron status by using the case-only approach specifically designed to estimate departure from multiplicative risk ratios under the assumption of independence between genotype and environmental exposure. The prevalence of the C282Y mutation was significantly higher in patients with hepatocellular carcinoma than in normal controls (8.6% vs 1.6%, P <0.03). At univariate analysis, iron overload was significantly associated with both HFE mutations (P <0.0001), whereas ongoing hepatitis B virus infection was associated with the C282Y mutation (P <0.05). By multivariate analysis, a trend for an increased risk of being positive for hepatitis virus markers (OR2.9, CI 95%0.9-9.5) and of having been alcohol abusers (OR3, CI 95%0.7-14) was observed in patients heterozygous for the HFE mutations, These data indicate that the prevalence of the main mutation associated with hereditary hemochromatosis is significantly higher in cirrhotic Italian patients with hepatocellular carcinoma compared to a normal population and suggest that heterozygotes for HFE mutations exposed to hepatitis virus infections or who had been alcohol abusers could have an increased risk of developing cirrhosis and later liver cancer than people without the mutations exposed to the same risk factors, (C) 2001 Academic Press.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 50 条
  • [1] Mutations of the HFE gene and the risk of hepatocellular carcinoma
    Racchi, O
    Mangerini, R
    Rapezzi, D
    Gaetani, GF
    Nobile, MT
    Picciotto, A
    Ferraris, AM
    BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (22) : 350 - 353
  • [2] HFE gene mutations and risk of hepatocellular carcinoma
    Herruzo, J. A. Solis
    Munoz, P. Solis
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2007, 99 (07) : 369 - 375
  • [3] Mutations of the HFE gene in patients, with hepatocellular carcinoma
    Cauza, E
    Peck-Radosavljevic, M
    Ulrich-Pur, H
    Datz, C
    Gschwantler, M
    Schöniger-Hekele, M
    Hackl, F
    Polli, C
    Rasoul-Rockenschaub, S
    Müller, C
    Wrba, F
    Gangl, A
    Ferenci, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (02): : 442 - 447
  • [4] HFE gene mutations in patients with hepatocellular carcinoma
    Hellerbrand, C
    Poeppl, A
    Hartmann, A
    Schoelmerich, J
    Lock, G
    HEPATOLOGY, 1999, 30 (04) : 583A - 583A
  • [5] HFE gene mutations in liver cirrhosis and hepatocellular carcinoma
    Sebastiani, G
    Benvegnù, L
    Angeli, P
    Pontisso, P
    Gatta, A
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2000, 32 : 154 - 154
  • [6] HFE gene mutations in patients with hepatocellular carcinoma.
    Hellerbrand, C
    Poeppl, A
    Hartmann, A
    Schoelmerich, J
    Lock, G
    GASTROENTEROLOGY, 2000, 118 (04) : A43 - A43
  • [7] HFE mutations in patients with hepatocellular carcinoma
    Cauza, E
    Ulrich-Pur, H
    Peck-Radosavljevic, M
    Novacek, G
    Gschwantler, M
    Polli, C
    Ferenci, P
    GASTROENTEROLOGY, 1999, 116 (04) : A1195 - A1195
  • [8] Frequency of the HFE gene mutations in cirrhotic patients with and without hepatocellular carcinoma
    Rodriguez, M
    Gonzalez, S
    Lauret, E
    Martinez-Borra, J
    Velazquez, RF
    Lopez-Vazquez, A
    Linares, A
    Lopez-Larrea, C
    Rodrigo, L
    HEPATOLOGY, 1999, 30 (04) : 281A - 281A
  • [9] Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis
    Nahon, Pierre
    Sutton, Angela
    Rufat, Pierre
    Ziol, Marianne
    Thabut, Gabriel
    Schischmanoff, Pierre-Olivier
    Vidaud, Dominique
    Charnaux, Nathalie
    Couvert, Philippe
    Ganne-Carrie, Nathalie
    Trinchet, Jean-Claude
    Gattegno, Liliane
    Beaugrand, Michel
    GASTROENTEROLOGY, 2008, 134 (01) : 102 - 110
  • [10] Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis
    Boige, V
    Castéra, L
    de Roux, N
    Ganne-Carrié, N
    Ducot, B
    Pelletier, G
    Beaugrand, M
    Buffet, C
    GUT, 2003, 52 (08) : 1178 - 1181